This page shows the latest cholera news and features for those working in and with pharma, biotech and healthcare.
Human challenge studies have been used previously to support the development of treatments for a range of disease, including malaria, typhoid, cholera, norovirus and influenza.
In the past, this type of trial has been used to investigate a range of diseases, including influenza, malaria, typhoid, dengue fever and cholera.
The CHMP also recommended PaxVax’s cholera vaccine Vaxchora for prophylaxis against choleam and Eli Lilly’s new fast-acting mealtime insulin Liumjev, to improve glycemic control in diabetes in adults.
Our research teams are collaborating with peers from organisations around the world to help in the development of effective treatments for diseases such as Chagas, cholera, dengue fever and schistosomiasis.
The approval also comes against the backdrop of a worldwide shortage in oral cholera vaccines, which include Valneva's Dukoral and the International Vaccine Institute's Shanchol. ... It is a live attenuated vaccine, incorporating a weakened strain of the
Sanofi Pasteur's vaccines currently cover 20 infectious diseases, including tuberculosis, cholera, influenza and hepatitis, and it is currently investigating a product to protect against the dengue virus.
More from news
Approximately 1 fully matching, plus 11 partially matching documents found.
Recommended reading: Love in the Time of Cholera by Gabriel Garcia Marquez, a story about how love can survive a lifetime of separation, including a cholera epidemic. ... The cholera epidemic of 1854 led the physician John Snow to conclude that the
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...